| Gene symbol | CEACAM5 | Synonyms | CD66e, CEA | Type of gene | protein-coding | |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | Entrez:1048 MIM:114890 HGNC:HGNC:1817 Ensembl:ENSG00000105388 AllianceGenome:HGNC:1817 | |
| Description | CEA cell adhesion molecule 5 | |||||
| GTO ID | GTC3048 |
| Trial ID | NCT05396300 |
| Disease | Colorectal Cancer | Esophageal Cancer | Pancreatic Cancer | Stomach Cancer |
| Altered gene | CEA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CEA CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | Weijia Fang, MD |
| Other ID(s) | PBC039 |
| Cohort 1 | |||||||||||
|
|||||||||||